Mar 12, 2019 / 09:00PM GMT
Operator
Ladies and gentlemen, greetings, and welcome to the Bellicum Pharmaceuticals Fourth Quarter and Full Year 2018 Financial Results. (Operator Instructions) As a reminder, this program is being recorded.
It is now my pleasure to introduce your host, Atabak Mokari, Chief Financial Officer. Thank you. You may begin.
Atabak Mokari - Bellicum Pharmaceuticals, Inc. - CFO
Thank you. Good afternoon, everyone, and thank you for joining the call. With me today is Rick Fair, Bellicum's President and Chief Executive Officer; Bill Grossman, Chief Medical Officer; and Aaron Foster, Head of Research.
Earlier this afternoon, Bellicum released financial results for the fourth quarter and full year ended December 31, 2018. If you have not received this release or if you would like to be added to the distribution list, you can do so on the Investor Relations page of the company's website.
As a reminder, today's conference call will include forward-looking statements made under the Private Securities Litigation Reform Act of 1995, including statements
Q4 2018 Bellicum Pharmaceuticals Inc Earnings Call Transcript
Mar 13, 2019
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers